Ellen Bonner, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Nashville office, was quoted in The Capitol Forum, in “Myriad: No Decision Expected at June 26 Meeting; Change to Current Local Coverage Determination Not Likely in Near-Term,” by Ethan Ehrenhaft.
Following is an excerpt:
Four Medicare Administrative Contractors will hold a teleconference/webinar meeting on Wednesday, June 26 with a multi-jurisdictional Contractor Advisory Committee (CAC) to review the efficacy of pharmacogenomic tests used to prescribe psychiatric medications. The tests involve sequencing patients’ genomes to assess how a patient may respond to different types of drug treatments. …
“The CAC is used to supplement the MAC’s internal expertise and to ensure an unbiased and contemporary consideration of ‘state of the art’ technology and science. The CAC is advisory in nature, with the final decision on all issues resting with the MACs,” Ellen C. Bonner, a lawyer at Epstein Becker Green, said in an email to The Capitol Forum.